{
  "id": 20506753,
  "title": "Earnings call transcript: IRIDEX Q3 2026 misses estimates as shares sink 25%",
  "url": "https://urgent.news/2026/11/17/earnings-call-transcript-iridex-q3-2026-misses-estimates-as-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-17T22:42:52.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-iridex-q3-2026-misses-estimates-as-shares-sink-25-93CH-5034275"
  },
  "original_language": "en",
  "account": null,
  "summary": "IRIDEX reported a wider-than-expected third-quarter loss and weaker revenue for Q3 2026, sending its shares down 25.4% in after-hours trading to $0.5221. The company posted an adjusted loss of $0.08 a share, compared with analysts’ estimate for a loss of $0.02, while revenue came in at $10.2 million versus expectations of $12.98 million. The results reflected sharp weakness in international retina sales, partly offset by stronger U.S. glaucoma performance and a steep improvement in gross margin.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}